Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …

Background The presence of mutation in EGFR gene is known as a predictive marker for the
response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) …

Objective This study evaluated the effect of EGFR mutation on early-stage non-small cell
lung cancer (NSCLC) based on the 8th TNM classification. Materials and methods The study …

Background Epidermal growth factor receptor (EGFR) gene mutations have an important
role for predicting the prognosis in advanced or recurrent lung cancer patients. However, the …

Objective Epidermal growth factor receptor (EGFR) gene mutation status is a well-
established predictor of the efficacy of EGFR tyrosine-kinase inhibitor (TKI) therapy in …

Background To elucidate the clinical, pathologic, and prognostic impacts of epidermal
growth factor receptor (EGFR) mutation and mutation subtypes in early-stage lung cancer …

Methods This single-center retrospective analysis included the group of 248 consecutive
patients with histopathologically confirmed non-small cell lung cancer diagnosed as …

Background Mutation of the EGFR gene is known as a predictor for the response to EGFR
tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in …

Introduction The prognostic value of epidermal growth factor receptor (EGFR) mutations and
the correlation between EGFR mutations and the new International Association for the Study …

The clinicopathological presentation of early-stage lung adenocarcinoma patients with
epidermal growth factor receptor (EGFR) mutations has been seldom studied. Our study …